Germany Diabetes Devices Market - Growth, Trends, and Forecasts (2017 - 2022)

Germany?s diabetes devices market is expected to account for USD XX billion, growing at a CAGR of XX% from USD XX billion in 2016. The diabetes devices mostly include all devices that are used to monitor, treat and manage diabetes. Major products in this market consist of glucose monitors, test strips, lancets and continuous blood glucose meters, among other similar products.

Germany Diabetes Devices Market-Market Dynamics

The German Diabetes Foundation predicts the number of diabetes cases in Germany to be around 8 million, which will help in the growth of the diabetes device market in the country.

Drivers

Germany?s diabetes devices market is being driven by many factors like:

Rise in the number of diabetes cases in Germany
Rapid innovations in developing new technologies
Increasing awareness
Improving diagnosis and treatment rates
Restraints

The cost of diagnosis, follow-up, maintenance and treatment of the disease, Germany?s new pricing and reimbursement policy leading to drug withdrawal and product patent expiry are restraining the growth of the diabetes device market.

Opportunities

The roll-out of many new drugs, increasing international research collaborations in technology advancement and increasing awareness about diabetes among the people are some of the market opportunities for the market players.

Challenges

Competition from biosimilars and generic drugs is a key challenge.

Germany?s diabetes devices market is broadly segmented based on the types into glucose monitoring devices market and the insulin delivery devices market. The glucose monitoring devices market is further segmented into blood glucose meter, blood glucose testing strip, lancet, continuous glucose monitoring device (CGM) and self-monitoring device. Based on insulin delivery devices, the market is further segmented as syringes, pens, pumps and injectors.

Some of the key players in the market are:

Bayer AG
Becton Dickinson
Boehringer Ingelheim
Cynosure, Inc.
Sanofi
Key Deliverables in the Study

Market analysis for Germany?s diabetes devices market, with region-specific assessments and competition analysis on a regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market.
Identification and analysis of the macro and micro factors that affect Germany?s diabetes device market on a regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

1. INTRODUCTION

1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast Period Years

1.6 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Models

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

5.1 Current Market Scenario

5.2 Technology Overview

5.3 New Developments in Therapeutics

5.4 Investment Analysis

5.5 Porter?s Five Force Analysis

5.5.1 Bargaining Power of Suppliers

5.5.2 Bargaining Power of Buyers

5.5.3 Degree of Competition

5.5.4 Threat of Substitution

5.5.5 Threat of New Entrants

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

6.1 Market Drivers

6.1.1 Rise in the number of diabetes cases in Germany

6.1.2 Rapid innovation in developing new technologies

6.1.3 Increasing awareness and improving diagnosis & treatment rates

6.2 Market Restraints

6.2.1 The cost of diagnosis, follow-up, maintenance and treatment of the disease

6.2.2 Germany's new pricing and reimbursement policy are leading to many drug withdrawals

6.2.3 Product patent expiry

6.3 Market Opportunities

6.3.1 The roll out of many new drugs

6.3.2 Increasing international research collaborations on technology advancement

6.3.3 Increasing awareness among people about diabetes

6.4 Key Challenges

6.4.1 Competition from biosimilars and generic drugs

7. Germany Diabetes Device Market Segmentation

7.1 By type

7.1.1 Glucose Monitoring Devices

7.1.1.1 Blood Glucose Meter

7.1.1.2 Blood Glucose Testing Strips

7.1.1.3 Lancets

7.1.1.4 Continuous Glucose Monitoring Device (CGM)

7.1.1.5 Self-Monitoring Glucose Device

7.1.1.6 Others

7.1.2 Insulin Delivery devices

7.1.2.1 Syringes

7.1.2.2 Pens

7.1.2.3 Pumps

7.1.2.4 Injectors

7.1.2.5 Others

8. Germany Diabetes Devices Market - Shares and Forecasts

9. Competitive Landscape

9.1 Mergers & Acquisitions

9.2 New Product Launches

9.3 Agreements, Collaborations & Partnerships

10. Key Vendors

10.1 Boehringer Ingelheim

10.2 Sanofi

10.3 Bayer AG

10.4 Cynosure, Inc.

10.5 Becton Dickinson

10.6 Medtronic

10.7 Abbott

10.8 Novo Nordisk

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

13. Appendix

13.1 Abbreviations

13.2 Bibliography

13.3 Disclaimer

Content are not available

Choose License Type